Research Article
Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy
Table 2
Associations between the SNPs and clinical parameters of gastric cancer patients.
| | rs10420321 | | rs16999593 | | rs2228612 | | rs2228611 | | rs2288349 | | | AA | AG + GG | TT | TC + CC | TT | TC + CC | GG | GA + AA | GG | GA + AA |
| | 130 | 257 | | 268 | 154 | | 137 | 285 | | 221 | 199 | | 237 | 182 | | Gender | | | | | | | | | | | | | | | | Male | 31.9 | 68.1 | 0.334 | 62.4 | 37.6 | 0.532 | 31.4 | 68.6 | 0.650 | 53.3 | 46.7 | 0.885 | 55.2 | 44.8 | 0.538 | Female | 36.9 | 63.1 | | 65.6 | 34.4 | | 33.6 | 66.4 | | 54.0 | 46.0 | | 58.4 | 41.6 | | Age | | | | | | | | | | | | | | | | ≤60 | 34.5 | 65.5 | 0.600 | 64.7 | 35.3 | 0.571 | 34.0 | 66.0 | 0.392 | 54.0 | 46.0 | 0.837 | 52.6 | 47.4 | 0.154 | >60 | 32.0 | 68.0 | | 62.1 | 37.9 | | 30.2 | 69.8 | | 53.0 | 47.0 | | 59.3 | 40.7 | | Tumor size | | | | | | | | | | | | | | | | ≤5 cm | 33.6 | 66.4 | 0.982 | 64.8 | 35.2 | 0.668 | 33.1 | 66.9 | 0.807 | 50.6 | 49.4 | 0.400 | 57.0 | 43.0 | 0.933 | >5 cm | 33.5 | 66.5 | | 62.8 | 37.2 | | 31.9 | 68.1 | | 54.7 | 45.3 | | 56.6 | 43.4 | | Pathological type | | | | | | | | | | | | | | | | Tubular adenocarcinoma | 32.2 | 67.8 | 0.393 | 62.8 | 37.2 | 0.889 | 31.3 | 68.7 | 0.414 | 54.6 | 45.4 | 0.507 | 55.6 | 44.4 | 0.853 | Signet ring cell carcinoma | 36.8 | 63.2 | | 65.2 | 34.8 | | 30.4 | 69.6 | | 47.8 | 52.2 | | 56.5 | 43.5 | | Others | 43.8 | 56.3 | | 66.7 | 33.3 | | 42.4 | 57.6 | | 45.5 | 54.5 | | 60.6 | 39.4 | | Differentiation | | | | | | | | | | | | | | | | Well to moderate | 37.6 | 62.4 | 0.191 | 61.1 | 38.9 | 0.501 | 34.4 | 65.6 | 0.458 | 57.7 | 42.3 | 0.152 | 54.5 | 45.5 | 0.646 | Poor | 31.1 | 68.9 | | 64.4 | 35.6 | | 30.9 | 69.1 | | 50.5 | 49.5 | | 56.8 | 43.2 | | TNM stage | | | | | | | | | | | | | | | | I/II | 29.6 | 70.4 | 0.065 | 62.9 | 37.1 | 0.710 | 29.4 | 70.6 | 0.183 | 52.0 | 48.0 | 0.618 | 58.5 | 41.5 | 0.354 | III/IV | 38.4 | 61.6 | | 64.6 | 35.4 | | 35.4 | 64.6 | | 54.4 | 45.6 | | 54.1 | 45.9 | | Lymph-vascular invasion | | | | | | | | | | | | | | | | Absent | 33.0 | 67.0 | 0.849 | 60.7 | 39.3 | 0.499 | 31.6 | 68.4 | 0.800 | 49.6 | 50.4 | 0.446 | 57.8 | 42.2 | 0.829 | Present | 34.0 | 66.0 | | 64.2 | 35.8 | | 32.9 | 67.1 | | 53.7 | 46.3 | | 56.6 | 43.4 | | Neural invasion | | | | | | | | | | | | | | | | Absent | 32.8 | 67.2 | 0.699 | 62.6 | 37.4 | 0.794 | 33.0 | 67.0 | 0.848 | 50.0 | 50.0 | 0.305 | 60.0 | 40.0 | 0.215 | Present | 34.7 | 65.3 | | 63.8 | 36.2 | | 32.1 | 67.9 | | 55.0 | 45.0 | | 54.1 | 45.9 | | Radical surgery | | | | | | | | | | | | | | | | Yes | 33.2 | 66.8 | 0.995 | 63.7 | 36.3 | 0.415 | 31.9 | 68.1 | 0.910 | 53.5 | 46.5 | 0.991 | 56.2 | 43.8 | 0.827 | No | 33.3 | 66.7 | | 53.3 | 46.7 | | 33.3 | 66.7 | | 53.3 | 46.7 | | 53.3 | 46.7 | | Chemotherapy | | | | | | | | | | | | | | | | No | 30.2 | 69.8 | 0.056 | 59.9 | 40.1 | 0.028 | 28.7 | 71.3 | 0.026 | 56.4 | 43.6 | 0.069 | 55.1 | 44.9 | 0.530 | Yes | 39.8 | 60.2 | | 70.7 | 29.3 | | 39.3 | 60.7 | | 47.1 | 52.9 | | 58.3 | 41.7 | |
|
|